Detalhe da pesquisa
1.
qSOFA combined with suPAR for early risk detection and guidance of antibiotic treatment in the emergency department: a randomized controlled trial.
Crit Care
; 28(1): 42, 2024 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38321472
2.
Host cystathionine-γ lyase derived hydrogen sulfide protects against Pseudomonas aeruginosa sepsis.
PLoS Pathog
; 17(3): e1009473, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33770141
3.
A novel optical biosensor for the early diagnosis of sepsis and severe Covid-19: the PROUD study.
BMC Infect Dis
; 20(1): 860, 2020 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33213370
4.
Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial.
Infect Dis Ther
; 10(4): 2333-2351, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34363189
5.
An open label trial of anakinra to prevent respiratory failure in COVID-19.
Elife
; 102021 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33682678
6.
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.
Nat Med
; 27(10): 1752-1760, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34480127
7.
Serum Hydrogen Sulfide and Outcome Association in Pneumonia by the SARS-CoV-2 Coronavirus.
Shock
; 54(5): 633-637, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32433216
8.
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure.
Cell Host Microbe
; 27(6): 992-1000.e3, 2020 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32320677
9.
Impaired antioxidative activity of high-density lipoprotein is associated with more severe acute ischemic stroke.
Metabolism
; 98: 49-52, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31202834
10.
Reply to Radermacher et al. on "Serum Hydrogen Sulfide and Outcome Association in Pneumonia by the SARS-CoV-2 Coronavirus".
Shock
; 55(1): 139-140, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32590691
11.
Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.
Nat Med
; 27(10): 1850, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34625750